MarginsXMarginsX
Home › Canada › CSE stocks › DRUG

Bright Minds Biosciences Inc. (CSE: DRUG)

DRUG trades on the Canadian Securities Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$32.75
-0.76% on the day
Market cap (C$)
C$250.1M
TMX list, November 13, 2026
Market cap (US$)
US$175.4M
Micro cap at 1.4257 C$/US$
1-year return
-60.2%
-70.3% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for DRUG.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 40-F text ("our website").

Profile

FieldValue
TickerDRUG on the Canadian Securities Exchange
Yahoo symbolDRUG.CN
SectorLife Sciences, Biotechnology
HeadquartersBritish Columbia
ListedThe TMX list gives no listing date
Listing typeTMX leaves listing type blank for long-listed issuers
Shares outstanding7,635,789
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIK0001827401
Websitewww.brightmindsbio.com
US listingDRUG

Returns

WindowReturn
1 day-0.8%
1 week+26.0%
1 month-56.1%
3 months-70.2%
6 months-71.8%
Year to date-70.3%
1 year-60.2%
From 52-week high-75.2%
52-week rangeC$26.00 to C$131.88

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

127 documents in 13 types. Each title links to the document at its source.

Annual financial statements (1)

Interim financial statements (6)

MD&A (7)

Annual information form (1)

News release (24)

Management information circular / proxy (5)

Report of voting results (1)

Prospectus (6)

Annual report (2)

DocumentTypeFiled
FORM 40-F
Period 2025-09-30
Annual report (40-F) (40-F)2025-12-23
FORM 20-F
Period 2024-09-30
Annual report (20-F) (20-F)2024-12-31

Early warning / ownership (36)

DocumentTypeFiled
Schedule 13D amendmentSchedule 13D (SCHEDULE 13D/A)2026-07-02
Schedule 13D amendmentSchedule 13D (SC 13D/A)2024-11-05
Schedule 13D amendmentSchedule 13D (SC 13D/A)2024-11-05
Schedule 13G amendmentSchedule 13G (SCHEDULE 13G/A)2026-11-16

Insider report (4)

DocumentTypeFiled
Form 3Form 3 (3)2024-10-17
Form 4Form 4 (4)2026-04-30
Form 4Form 4 (4)2024-11-06
Form 4Form 4 (4)2024-10-17

Certification (18)

DocumentTypeFiled
Certification of Interim Filings - CEOCertification (52-109F2) (6-K)2026-08-17
Certification of Interim Filings - CFOCertification (52-109F2) (6-K)2026-08-17
Certification of Interim Filings - CEOCertification (52-109F2) (6-K)2026-05-20
Certification of Interim Filings - CFOCertification (52-109F2) (6-K)2026-05-20

Other (16)

DocumentTypeFiled
Consent of De Visser Gray LLP, Independent Registered Public Accounting Firm
Period 2025-09-30
Consent (40-F)2025-12-23
EXHIBIT 5.1Consent (F-3)2025-08-26
EXHIBIT 23.1Consent (F-3)2025-08-26
EXHIBIT 5.1Consent (F-3)2025-02-05

Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2024-11-19EquityUS$34.6MUS$34.6MSEC EDGAR
2024-10-22Option To Acquire, Security To Be AcquiredUS$0US$12KSEC EDGAR
2024-05-03Equity, Option To Acquire, Security To Be Acquired, OtherUS$0US$54KSEC EDGAR
2022-09-14Option To Acquire, Security To Be AcquiredUS$0US$150KSEC EDGAR
2022-09-01Equity, Option To Acquire, Security To Be Acquired, OtherUS$0US$220KSEC EDGAR

Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
WSTRWELLSTAR Technologies Corp.TSXVC$263.9M-13.3%Under a year of closes
CRRXCareRx CorporationTSXC$213.7M-3.0%0.0%
EDTSpectral Medical Inc.TSXC$303.5M-9.1%-25.9%
TSNDTerrAscend Corp.TSXC$204.1M-20.6%-36.5%
MSCLSatellos Bioscience Inc.TSXC$202.4M-4.0%+14.7%

The app has the price chart, every filing, private raises and the full peer set for DRUG.

Open in the app